ADiTx Therapeutics DSO Ratio 2011-2026 | ADTX

Annual DSO Ratio ADiTx Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
621	116	17.6	156	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
621	17.6	227

Quarterly DSO Ratio ADiTx Therapeutics

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
10.8 K	10.8 K	-	5.05 K	859	478	-	272	146	179	-	152	140	73.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
10.8 K	73.5	2.63 K

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Processa Pharmaceuticals PCSA	7.47	$ 2.3	-1.29 %	$ 3.01 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 220.9	2.49 %	$ 5 B	Danmark
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 19.57	1.77 %	$ 915 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Phathom Pharmaceuticals PHAT	122	$ 10.47	4.08 %	$ 763 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Pliant Therapeutics PLRX	37.6	$ 1.31	2.34 %	$ 80.4 M	USA
Corbus Pharmaceuticals Holdings CRBP	239	$ 8.31	1.59 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	1.1 K	$ 47.09	1.42 %	$ 4.23 B	Schweiz
Cyclacel Pharmaceuticals CYCC	81.5 K	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Dynavax Technologies Corporation DVAX	56.5	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Palatin Technologies PTN	119	$ 21.0	5.79 %	$ 19.5 M	USA
Pulmatrix PULM	21.7	$ 2.12	-1.4 %	$ 7.74 M	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.53	5.1 %	$ 868 M	Canada